Roche Molecular Systems Organizational Development Manager Salaries in Boulder
The average Roche Molecular Systems Organizational Development Manager in Boulder earns an estimated $116,977 annually, which includes an estimated base salary of $101,144 with a $15,833 bonus. Roche Molecular Systems' Organizational Development Manager compensation is $14,753 more than the US average for a Organizational Development Manager. Organizational Development Manager salaries at Roche Molecular Systems in Boulder can range from $63,585 - $157,500.
In Boulder, The HR Department at Roche Molecular Systems earns $10,649 more on average than the IT Department.
Last updated 2 years ago.
- $101,144
- avg. base
- $15,833
- avg. bonus
Organizational Development Manager Salaries at Roche Molecular Systems
In Boulder, Organizational Development Managers earn $4,225 more than HR Managers, and $66,586 less than Directors of HR.
Compensation at Roche Molecular Systems by Department
In Boulder, The HR Department averages $10,649 more than the IT Department, and $5,058 less than the Legal Department
Organizational Development Manager Compensation by Gender (All Companies)
The average female Organizational Development Manager at companies similar size to Roche Molecular Systems reported making $116,859, while the average male Organizational Development Manager at similar sized companies reported making $136,237.
Organizational Development Manager Compensation by Ethnicity (All Companies)
The average Native American Organizational Development Manager at companies similar size to Roche Molecular Systems reported making $160,000, while the average Caucasian Organizational Development Manager at similar sized companies reported making $114,466.
How Organizational Development Managers at Roche Molecular Systems Rate Their Compensation
The majority of Organizational Development Managers at Roche Molecular Systems believe they're compensated fairly. 100% of Organizational Development Managers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
